CN1046277C - 喹诺酮衍生物制备方法和用途 - Google Patents

喹诺酮衍生物制备方法和用途 Download PDF

Info

Publication number
CN1046277C
CN1046277C CN94190297A CN94190297A CN1046277C CN 1046277 C CN1046277 C CN 1046277C CN 94190297 A CN94190297 A CN 94190297A CN 94190297 A CN94190297 A CN 94190297A CN 1046277 C CN1046277 C CN 1046277C
Authority
CN
China
Prior art keywords
compound
salt
reaction
group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94190297A
Other languages
English (en)
Chinese (zh)
Other versions
CN1110056A (zh
Inventor
西孝夫
宇野哲之
朱吉男
田村克己
冈田稔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of CN1110056A publication Critical patent/CN1110056A/zh
Application granted granted Critical
Publication of CN1046277C publication Critical patent/CN1046277C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Saccharide Compounds (AREA)
CN94190297A 1993-05-19 1994-05-11 喹诺酮衍生物制备方法和用途 Expired - Fee Related CN1046277C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP116764/93 1993-05-19
JP11676493 1993-05-19

Publications (2)

Publication Number Publication Date
CN1110056A CN1110056A (zh) 1995-10-11
CN1046277C true CN1046277C (zh) 1999-11-10

Family

ID=14695161

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94190297A Expired - Fee Related CN1046277C (zh) 1993-05-19 1994-05-11 喹诺酮衍生物制备方法和用途

Country Status (16)

Country Link
US (1) US5541198A (cg-RX-API-DMAC7.html)
EP (1) EP0651747B1 (cg-RX-API-DMAC7.html)
JP (1) JP2742983B2 (cg-RX-API-DMAC7.html)
KR (1) KR0174111B1 (cg-RX-API-DMAC7.html)
CN (1) CN1046277C (cg-RX-API-DMAC7.html)
AT (1) ATE136029T1 (cg-RX-API-DMAC7.html)
AU (1) AU671026B2 (cg-RX-API-DMAC7.html)
BR (1) BR1100189A (cg-RX-API-DMAC7.html)
CA (1) CA2139332A1 (cg-RX-API-DMAC7.html)
DE (1) DE69400117T2 (cg-RX-API-DMAC7.html)
DK (1) DK0651747T3 (cg-RX-API-DMAC7.html)
ES (1) ES2088320T3 (cg-RX-API-DMAC7.html)
GR (1) GR3020125T3 (cg-RX-API-DMAC7.html)
PH (1) PH30366A (cg-RX-API-DMAC7.html)
TW (1) TW289019B (cg-RX-API-DMAC7.html)
WO (1) WO1994026732A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046593A1 (en) * 1997-04-16 1998-10-22 Otsuka Pharmaceutical Co., Ltd. Novel carbostyril derivative

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008274A (en) * 1986-04-02 1991-04-16 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and pharmaceutical composition for inhibiting adhesion of thrombocytes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57159778A (en) * 1981-03-27 1982-10-01 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPH0681752B2 (ja) * 1986-04-02 1994-10-19 大塚製薬株式会社 カルボスチリル誘導体
JPH0681727B2 (ja) * 1986-04-02 1994-10-19 大塚製薬株式会社 血小板粘着抑制剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008274A (en) * 1986-04-02 1991-04-16 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and pharmaceutical composition for inhibiting adhesion of thrombocytes

Also Published As

Publication number Publication date
EP0651747A1 (en) 1995-05-10
PH30366A (en) 1997-04-02
TW289019B (cg-RX-API-DMAC7.html) 1996-10-21
AU6690494A (en) 1994-12-12
DE69400117T2 (de) 1996-08-22
HK1002705A1 (en) 1998-09-11
CN1110056A (zh) 1995-10-11
JPH0733765A (ja) 1995-02-03
EP0651747B1 (en) 1996-03-27
JP2742983B2 (ja) 1998-04-22
GR3020125T3 (en) 1996-08-31
US5541198A (en) 1996-07-30
ATE136029T1 (de) 1996-04-15
DE69400117D1 (de) 1996-05-02
AU671026B2 (en) 1996-08-08
ES2088320T3 (es) 1996-08-01
WO1994026732A1 (en) 1994-11-24
KR0174111B1 (ko) 1999-02-01
CA2139332A1 (en) 1994-11-24
BR1100189A (pt) 2000-08-01
KR950702552A (ko) 1995-07-29
DK0651747T3 (da) 1996-05-20

Similar Documents

Publication Publication Date Title
CA2765015C (en) Deuterated isoindoline-1,3-dione derivatives as pde4 and tnf-alpha inhibitors
CN1015057B (zh) 哌嗪基-杂环化合物的制备方法
CN1179160A (zh) 2－甲基－噻吩并苯并二氮杂䓬的结晶形式及制备方法
CN87107175A (zh) 作为抗溃疡剂的新苯并咪唑衍生物
CN102558022B (zh) 取代的异吲哚啉-1,3二酮衍生物
CN1075480A (zh) 新型芳基羰基氨基烷基-二氢-氧代吡啶类化合物及其生产与应用
CN1046517C (zh) 三唑并哒嗪,其制备和应用
CN1046277C (zh) 喹诺酮衍生物制备方法和用途
CN1606557A (zh) 经氘代的吡唑嘧啶酮以及包含该化合物的药物组合物
CN101048392A (zh) 新用途
CN101054380A (zh) 用作细胞周期依赖性蛋白激酶抑制剂的吡唑并嘧啶类衍生物
CN1267416C (zh) 新的5－羟基氨基甲酰亚氨基－2－羟基苯磺酰胺衍生物晶体
CN1094126C (zh) 吡咯并吖庚因化合物
CN1278252A (zh) 4,5－二芳基噁唑类化合物
CN1788007A (zh) 苯并咪唑衍生物的晶体及其生产方法
CN1150420A (zh) 4-喹啉酮衍生物及其盐
CN1179940C (zh) 1,2-二苯基-2-丙烯-1-酮衍生物
KR101900498B1 (ko) 치환된 아이소인돌린-1,3-다이온 유도체
JP2011524351A (ja) Ｃｂ１アンタゴニスト活性を有するフルオロ置換された３，４−ジアリール−４，５−ジヒドロ−１ｈ−ピラゾール−１−カルボキサミジン誘導体
HK1002705B (en) Carbostyryl derivatives
CN1918173A (zh) 新颖的茚并[2,1a]茚和异吲哚并[2,1－a]吲哚
CN1100418A (zh) 2-氨基-5-氰基-4-喹啉基二氢吡啶酯及其制法与药用
HK1169651B (en) Deuterated isoindoline-1,3-dione derivatives as pde4 and tnf-alpha inhibitors
HK1194725A (en) Deuterated isoindoline-1,3-dione derivatives as pde4 and tnf-alpha inhibitors

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee